Suppr超能文献

高流量鼻导管吸氧在老年患者异丙酚镇静胃镜检查中不同吸入氧浓度的效果:一项随机对照研究。

The effect of varying inhaled oxygen concentrations of high-flow nasal cannula oxygen therapy during gastroscopy with propofol sedation in elderly patients: a randomized controlled study.

机构信息

Department of Anesthesiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

出版信息

BMC Anesthesiol. 2022 Nov 2;22(1):335. doi: 10.1186/s12871-022-01879-z.

Abstract

BACKGROUND

Despite evidence that high-flow nasal cannula oxygen therapy (HFNC) promotes oxygenation, its application in sedated gastroscopy in elderly patients has received little attention. This study investigated the effect of different inhaled oxygen concentrations (FiO) of HFNC during sedated gastroscopy in elderly patients.

METHODS

In a prospective randomized single-blinded study, 369 outpatients undergoing regular gastroscopy with propofol sedation delivered by an anesthesiologist were randomly divided into three groups (n = 123): nasal cannula oxygen group (Group C), 100% FiO of HFNC group (Group H100), and 50% FiO of HFNC (Group H50). The primary endpoint in this study was the incidence of hypoxia events with pulse oxygen saturation (SpO) ≤ 92%. The secondary endpoints included the incidence of other varying degrees of hypoxia and adverse events associated with ventilation and hypoxia.

RESULTS

The incidence of hypoxia, paradoxical response, choking, jaw lift, and mask ventilation was lower in both Group H100 and Group H50 than in Group C (P < 0.05). Compared with Group H100, Group H50 showed no significant differences in the incidence of hypoxia, jaw lift and mask ventilation, paradoxical response, or choking (P > 0.05). No patients were mechanically ventilated with endotracheal intubation or found to have complications from HFNC.

CONCLUSION

HFNC prevented hypoxia during gastroscopy with propofol in elderly patients, and there was no significant difference in the incidence of hypoxia when FiO was 50% or 100%.

TRIAL REGISTRATION

This single-blind, prospective, randomized controlled trial was approved by the Ethics Committee of Nanjing First Hospital (KY20201102-04) and registered in the China Clinical Trial Center (20/10/2021, ChiCTR2100052144) before patients enrollment. All patients signed an informed consent form.

摘要

背景

尽管高流量鼻导管给氧治疗(HFNC)能改善氧合,但在老年患者镇静胃镜检查中的应用却很少受到关注。本研究旨在探讨不同吸入氧浓度(FiO)的 HFNC 在老年患者镇静胃镜检查中的应用效果。

方法

前瞻性随机单盲研究中,369 例接受异丙酚镇静下常规胃镜检查的门诊患者,由麻醉医师给予经鼻导管给氧,随机分为三组(每组 123 例):鼻导管给氧组(C 组)、HFNC 100% FiO 组(H100 组)和 HFNC 50% FiO 组(H50 组)。本研究的主要终点是脉搏血氧饱和度(SpO)≤92%的缺氧事件发生率。次要终点包括其他不同程度缺氧及与通气和缺氧相关的不良事件发生率。

结果

与 C 组相比,H100 组和 H50 组的缺氧、矛盾反应、呛咳、下颌上抬和面罩通气发生率较低(P<0.05)。与 H100 组相比,H50 组在缺氧、下颌上抬和面罩通气、矛盾反应和呛咳的发生率方面无显著差异(P>0.05)。没有患者需要机械通气行气管插管,也没有发现 HFNC 相关并发症。

结论

HFNC 可预防老年患者行异丙酚镇静胃镜检查时发生缺氧,FiO 为 50%或 100%时,缺氧发生率无显著差异。

试验注册

本单盲、前瞻性、随机对照试验获得南京第一医院伦理委员会批准(KY20201102-04),并在中国临床试验中心注册(2020 年 10 月 20 日,ChiCTR2100052144),随后开始患者入组。所有患者均签署知情同意书。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb20/9628057/fbc5cec835d2/12871_2022_1879_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验